PTC Therapeutics | PTCT - 流动负债



金融业
股票价格
USD
资产
USD 2.87B
现金及等价物
USD 833.99M
销售成本
USD 39.61M
流动资产
USD 2.25B
流动负债
USD 923.6M
债务
USD 286.94M
EBIT
USD 45.89M
EBITDA
USD -70.99M
员工
939
EPS每股收益
USD -0.03
股本和储备
USD -180.47M
销售毛利
USD 232.94M
债务利息支出
USD 2.87B
贷款资金
USD 286.94M
市值
USD 5.35B
净收入
USD -2.81M
营业费用
USD 226.67M
营业利润
USD 45.89M
普通股股本
USD 81.47M
PE价格收益
9.98
税前利润
USD -2.46M
销售收入
USD 273M
销售和管理费用
USD 73.89M
股票
USD 75.57M
贸易债权人
USD 25.48M
应收帐款人
USD 181.62M


流动负债 更改 日
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
Amgen USD 24.96B 534M 2026-03
BioCryst Pharmaceuticals USD 195.39M 675K 2026-03
Biogen USD 3B 350.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Cytokinetics USD 199.18M 3.27M 2026-03
Daiichi Sankyo JPY 778.55B 77.51B 2025-12
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Esperion Therapeutics USD 300.36M 451K 2026-03
Gilead Sciences USD 9.48B 2.34B 2026-03
Incyte USD 1.49B 25.52M 2026-03
Ionis Pharmaceuticals USD 717M 66M 2026-03
Ironwood Pharmaceuticals USD 236.31M 5.91M 2026-03
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Novartis USD 31.37B 4.1B 2026-03
Pfizer USD 34.35B 2.64B 2026-03
PTC Therapeutics USD 923.6M 44.82M 2026-03
Puma Biotechnology USD 82.73M 3.63M 2025-09
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
TG Therapeutics USD 187.11M 33.35M 2026-03
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03
Xencor USD 73.46M 22.45M 2026-03